Medicare Enrolled

Dr. Ying Hu

Endocrinology · Wynnewood, PA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
100 E LANCASTER AVE STE 560, Wynnewood, PA 19096
6106491922
In practice since 2008 (17 years)
NPI: 1134370018 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Hu from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hu? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Hu

Dr. Ying Hu is an endocrinology specialist in Wynnewood, PA, with 17 years of NPI registration. Based on federal Medicare data, Dr. Hu performed 2,946 Medicare services across 460 unique beneficiaries.

Between the years covered by Open Payments, Dr. Hu received a total of $16,420 from 52 pharmaceutical and/or device companies across 810 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Hu is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice ▲ Top 14% volume in PA $16,420 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,946
Medicare services
Top 14% in PA for endocrinology
460
Unique beneficiaries
$32
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~173 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Denosumab injection (Prolia/Xgeva) 2,280 $18 $55
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
250 $89 $235
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
191 $64 $150
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
59 $12 $62
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
50 $104 $296
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
41 $120 $364
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
23 $143 $337
Continuous glucose monitoring with interpretation
This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results.
22 $26 $100
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
17 $46 $150
Telephone medical discussion, 21-30 minutes
A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone.
13 $89 $225
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$16,420
Total received (2018-2024)
Avg $2,346/year across 7 years
Top 17% in PA for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
52
Companies
810
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$16,420 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,615
2023
$2,509
2022
$2,621
2021
$1,824
2020
$2,150
2019
$3,680
2018
$20

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Medtronic, Inc.
$1,200
Lilly USA, LLC
$728
Novo Nordisk Inc
$562
Dexcom, Inc.
$212
Amgen Inc.
$196
Gilead Sciences, Inc.
$121
SANOFI-AVENTIS U.S. LLC
$67
ABBVIE INC.
$64
Amphastar Pharmaceuticals, Inc.
$54
Tandem Diabetes Care, Inc.
$53
Xeris Pharmaceuticals, Inc.
$52
Boehringer Ingelheim Pharmaceuticals, Inc.
$52
Mannkind Corporation
$47
IBSA Pharma Inc.
$38
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$37
Bayer Healthcare Pharmaceuticals Inc.
$34
Alexion Pharmaceuticals, Inc.
$31
Ascensia Diabetes Care Us Inc.
$28
Averitas Pharma Inc.
$24
TheracosBio, LLC
$14
Top 3 companies account for 68.9% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$2,735
Lilly USA, LLC
$2,317
Medtronic, Inc.
$1,521
Amgen Inc.
$1,387
SANOFI-AVENTIS U.S. LLC
$956
Dexcom, Inc.
$847
AstraZeneca Pharmaceuticals LP
$589
Merck Sharp & Dohme Corporation
$572
Boehringer Ingelheim Pharmaceuticals, Inc.
$494
Amarin Pharma Inc.
$450
Xeris Pharmaceuticals, Inc.
$448
Mannkind Corporation
$312
AbbVie, Inc.
$309
Amneal Pharmaceuticals LLC
$302
Gilead Sciences, Inc.
$300
Radius Health, Inc.
$277
Merck Sharp & Dohme LLC
$257
ABBVIE INC.
$195
AbbVie Inc.
$150
IBSA Pharma Inc.
$141
Tandem Diabetes Care, Inc.
$137
Medtronic MiniMed, Inc.
$134
Bayer Healthcare Pharmaceuticals Inc.
$127
Allergan Inc.
$117
Alexion Pharmaceuticals, Inc.
$115
DEXCOM, INC.
$112
Ipsen Biopharmaceuticals, Inc
$94
Insulet Corporation
$92
Companion Medical, Inc.
$80
Abbott Laboratories
$77
Corcept Therapeutics
$66
Averitas Pharma Inc.
$64
GRT US Holding, Inc.
$60
MannKind Corporation
$59
Amphastar Pharmaceuticals, Inc.
$54
EISAI INC.
$54
Shire North American Group Inc
$49
Becton, Dickinson and Company
$47
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$37
Kyowa Kirin, Inc.
$36
Janssen Pharmaceuticals, Inc
$33
Ascensia Diabetes Care Us Inc.
$28
Zealand Pharma US, Inc.
$26
Bayer HealthCare Pharmaceuticals Inc.
$24
Takeda Pharmaceuticals U.S.A., Inc.
$24
Embecta Corp.
$22
Regeneron Healthcare Solutions, Inc.
$20
Ultragenyx Pharmaceutical Inc.
$16
Tolmar, Inc.
$15
TheracosBio, LLC
$14
Currax Pharmaceuticals LLC
$13
Ferring Pharmaceuticals Inc.
$12
Top 3 companies account for 40.0% of all-time payments
Associated products mentioned in payments ›
AFREZZA · BAQSIMI · BD Nano · BD Nano 2nd Gen Pen Needle · BELSOMRA · Belviq · Brenzavvy · CONTRAVE · CYCLOSET · Crysvita · Cryvista · DEXCOM G6 CGM SYSTEM · DEXCOM G6 TRANSMITTER · Dexcom G6 Transmitter · EVENITY · EVERSENSE E3 SENSOR KIT - RETAIL · FARXIGA · FreeStyle Libre · GATTEX · GVOKE HYPOPEN · GVOKE PFS · Guardian Connect · HUMULIN · HUMULIN R 500 · INPEN SMART INSULIN DELIVERY SYSTEM · INVOKANA · InPen · JANUVIA · JARDIANCE · JATENZO · Kerendia · Korlym · LICART · MINIMED 770G · MINIMED 780G · MOUNJARO · Macrilen · Minimed 670G System · Minimed 770G System · NATPARA (PARATHYROID HORMONE) · Omnipod · Ozempic · PRALUENT · Prolia · QUTENZA · Qutenza · RECORLEV · RYBELSUS · Repatha · Rybelsus · SOLIQUA 100/33 · SOMATULINE DEPOT · STEGLATRO · STEGLUJAN · STRENSIQ · SYNTHROID · Saxenda · Strensiq · Synthroid · TEPEZZA · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Tirosint · Tresiba · Tymlos · UBRELVY · UNITHROID · V-GO · Vascepa · Vemlidy · Wegovy · XARELTO · ZENPEP · ZEPBOUND · ZOMACTON · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ · t:slim X2 insulin pump
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an endocrinology specialist in Wynnewood?
Compare endocrinologists in the Wynnewood area by procedure volume, costs, and industry payment transparency.
Browse endocrinologists nearby

Geographic Context

Endocrinologists within 10 mi
202
Per 100K population
23.5
County median income
$111,521
Nearest hospital
MAIN LINE HOSPITAL LANKENAU
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Hu is a mixed practice specialist, with above-average Medicare volume (top 14% in PA), with low-engagement industry engagement in the top 17% of PA peers, with 17 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Hu experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Hu performed 2,280 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Hu receive payments from pharmaceutical companies?
Yes. Dr. Hu received a total of $16,420 from 52 companies across 810 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hu's costs compare to other endocrinologists in Wynnewood?
Dr. Hu's average Medicare payment per service is $32. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hu) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →